TOP2A and breast cancer: Among the 24 DEGs identified, notable dysregulation of gene expression was observed in IDC (which presented 23 DEGs—21 of them overexpressed), including several genes previously implicated in BC, such as IGF1, TOP2A, FOXM1, and TPX2, which served to validate our approach.